BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10021 related articles for article (PubMed ID: 16569355)

  • 1. Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior?
    Staibano S; Mascolo M; Tranfa F; Salvatore G; Mignogna C; Bufo P; Nugnes L; Bonavolontà G; De Rosa G
    Int J Immunopathol Pharmacol; 2006; 19(1):171-9. PubMed ID: 16569355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
    Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
    Shukuwa T; Katayama I; Koji T
    Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes.
    Hallermalm K; De Geer A; Kiessling R; Levitsky V; Levitskaya J
    Cancer Res; 2004 Sep; 64(18):6775-82. PubMed ID: 15374996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
    Dworacki G; Meidenbauer N; Kuss I; Hoffmann TK; Gooding W; Lotze M; Whiteside TL
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):947s-957s. PubMed ID: 11300496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
    Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T
    Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
    Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
    Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.
    Bronkhorst IH; Vu TH; Jordanova ES; Luyten GP; Burg SH; Jager MJ
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5370-8. PubMed ID: 22743317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer.
    Ferrandina G; Ranelletti FO; Legge F; Salutari V; Martinelli E; Fattorossi A; Lorusso D; Zannoni G; Vellone V; Paglia A; Scambia G
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2055-60. PubMed ID: 16609015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
    Ryan AE; Shanahan F; O'Connell J; Houston AM
    Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas ligand expression in metastatic renal cell carcinoma during interleukin-2 based immunotherapy: no in vivo effect of Fas ligand tumor counterattack.
    Donskov F; von der Maase H; Marcussen N; Hamilton-Dutoit S; Madsen HH; Jensen JJ; Hokland M
    Clin Cancer Res; 2004 Dec; 10(23):7911-6. PubMed ID: 15585624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The expression of zeta-chain of the T cell receptor as prognostic marker for patients with head and neck cancer].
    Müller D; Lang S; Roskrow M; Wollenberg B
    Laryngorhinootologie; 2002 Jul; 81(7):516-20. PubMed ID: 12173063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAS, FAS ligand, tumor infiltrating lymphocytes, and macrophages in malignant melanoma: an immunohistochemical study.
    Bozdogan N; Bozdogan O; Pak I; Atasoy P
    Int J Dermatol; 2010 Jul; 49(7):761-7. PubMed ID: 20618494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and histopathological aspects of 113 necrotizing malignant melanomas of the choroid. 2. Immunogenetic characterization of T-cell receptor-positive tumor-infiltrating lymphocytes and survival of patients with necrotizing melanomas of the choroid].
    Bialasiewicz AA; Ma JX; Richard G
    Klin Monbl Augenheilkd; 1998 Nov; 213(5):271-7. PubMed ID: 9888131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of macrophage and lymphocyte, but not dendritic cell, infiltration in posterior uveal melanomas, whilst cultured uveal melanomas demonstrate pluripotency by expressing CD68 and CD163.
    Woodward J; Sisley K; Reeves G; Nichols C; Parsons MA; Mudhar H; Rennie I
    Int J Exp Pathol; 2004 Feb; 85(1):35-43. PubMed ID: 15113392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma.
    Reichert TE; Day R; Wagner EM; Whiteside TL
    Cancer Res; 1998 Dec; 58(23):5344-7. PubMed ID: 9850063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 502.